click here to download this circular as a pdf

TO:
HEADS OF PROVINCIAL HEALTH DEPARTMENTS DISTRICT,
HOSPITAL AND PHC MANAGERS
COVID-19 VACCINE PROGRAMME MANAGERS
COVID-19 VACCINATION SITE MANAGERS
COVID-19 VACCINATORS

SUBJECT: PROVISION OF BOOSTER DOSES OF COVID VACCINES

  1. From 24th December 2021, individuals older than 18 years of age who have received one dose of the Janssen® Covid (J&J) vaccine will be eligible to receive a booster dose of the Janssen® vaccine after an interval of two months (60 days).

    1.1. The recommended interval between the previous and the booster dose of the Janssen® vaccine is two months (60 days). Whilst the booster dose should preferably be given within six months of the previous dose, there is no upper limit to the interval i.e. the booster dose can be given more than six months after the first dose.

    1.2. In practice this means that anyone who received one dose of the Janssen® vaccine on or before the 24th October 2021, will immediately be eligible to receive a booster dose of the Janssen® vaccine. Additional individuals will sequentially become eligible once the interval of 60 days has elapsed.

    1.3. Immunocompromised individuals who have received an additional dose of the Janssen® vaccine will become eligible to receive a booster dose 60 days after receiving the additional dose.

  2. From 28th December 2021, individuals over the age of 18 years who have received two doses of the Pfizer Cominarty® vaccine will be eligible to receive a booster dose of the Cominarty® vaccine after an interval of six months (180 days).

    2.1. The recommended interval between an individual receiving their second dose of the Cominarty® vaccine, and the booster dose is six months (180 days). However, there is no upper limit to the interval i.e. the booster dose can be given more than 180 days after the second dose.

    2.2. The first people to receive their second dose of Cominarty® vaccine as part of the vaccine roll-out will become eligible to receive a booster on 28th December 2021. Thereafter other individuals will sequentially become eligible to receive the booster dose once the period of 180 days has elapsed.

    2.3. Immunocompromised individuals who have received an additional dose of the Cominarty® vaccine will become eligible to receive a booster dose 180 days after receiving the additional dose of the Cominarty® vaccine.

  3. The following should be noted:
    3.1 Only homologous boosting is currently permitted i.e. individuals may only receive the same vaccine that they received as their primary vaccination series.

    3.2 All procedures regarding provision of primary doses remain unchanged during provision of booster doses.

    3.3 All booster doses must be correctly recorded on the EVDS.

DR SSS BUTHELEZI DIRECTOR-GENERAL: HEALTH
DATE: 23 December 2021